Stoppa Am

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients

Benjamin Hébraud, Xavier Leleu, V. Lauwers‐Cancès et al. · Leukemia · 2013 · 102 citations

Hematological Malignancy, Ifm Experience, Medicine +7

Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma

Hugues de Lavallade, Jean El Cheikh, Catherine Faucher et al. · Bone Marrow Transplantation · 2008 · 68 citations

Hematological Malignancy, Relapsed Multiple Myeloma, Medicine +6

Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission.

Didier Blaise, MH Gaspard, Stoppa Am et al. · PubMed · 1990 · 66 citations

Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.

Harousseau Jl, Michel Attal, Marine Diviné et al. · PubMed · 1995 · 51 citations

Efficacy of bendamustine in relapsed/refractory myeloma patients: results from the French compassionate use program

Gandhi Damaj, Florent Malard, Cyrille Hulin et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 44 citations

Hematological Malignancy, Medicine, Metronomic Therapy +11